← All trials
NCT00154180
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2005
- Primary completion
- May 1, 2012
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 728
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Kronos Longevity Research InstituteLead sponsor
- University of Southern CaliforniaOverall official - principal investigator
- University of California, Los AngelesOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
- University of WisconsinOverall official - principal investigator
- Tufts UniversityOverall official - principal investigator
- Kronos Longevity Research InstituteStudy director
- Columbia UniversityCollaborator
- Mayo ClinicCollaborator
- University of California, San FranciscoCollaborator
- University of UtahCollaborator
- University of WashingtonCollaborator
- Yale UniversityCollaborator
- Yeshiva UniversityCollaborator
- Harvard UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.